Sodium Carbonate → (E)-4-Fluoro-1-[4-(2-methyl-4-quinolyl)piperazin-1-yl]pent-2-en-1-one
反応式
O[CH:2]([CH3:24])/[CH:3]=[CH:4]/[C:5]([N:7]1[CH2:12][CH2:11][N:10]([C:13]2[C:22]3[C:17](=[CH:18][CH:19]=[CH:20][CH:21]=3)[N:16]=[C:15]([CH3:23])[CH:14]=2)[CH2:9][CH2:8]1)=[O:6].C(N(S(F)(F)[F:31])CC)C.C(=O)([O-])[O-].[Na+].[Na+]>ClCCl>[F:31][CH:2]([CH3:24])/[CH:3]=[CH:4]/[C:5]([N:7]1[CH2:12][CH2:11][N:10]([C:13]2[C:22]3[C:17](=[CH:18][CH:19]=[CH:20][CH:21]=3)[N:16]=[C:15]([CH3:23])[CH:14]=2)[CH2:9][CH2:8]1)=[O:6]参加物
5
実験手順
(E)-4-Hydroxy-1-[4-(2-methyl-4-quinolyl)piperazin-1-yl]pent-2-en-1-one (32.5 mg, 0.1 mmol) was dissolved in anhydrous dichloromethane (200 μl) and added to a solution of (diethylamino)sulphur trifluoride (DAST; 19 μl, 0.12 mmol) in 200 μl dichloromethane. The mixture was stirred for 30 minutes at room temperature, additional DAST was added (10 μl, 0.063 mmol) and stirring was continued for additional 30 minutes. Solid sodium carbonate (25 mg) was added, the mixture was filtered, the filtrate evaporated to dryness and the residue purified by preparative HPLC (gradient of water containing 0.1% NH3 and acetonitrile) to yield 4 mg (0.012 mmol, 12%).
後処理
- stirringstirring
- waitwas continued for additional 30 minutes
- filtrationthe mixture was filtered
- customthe filtrate evaporated to dryness
- customthe residue purified by preparative HPLC (gradient of water containing 0.1% NH3 and acetonitrile)
- customto yield 4 mg (0.012 mmol, 12%)
出典と根拠
- ORDレコード
- ord-6bf75af861a74a5d9256c2e2ffcf0118
- 出典データセット
- uspto-grants-2014_11
- 特許番号
- US08883791B2
反応ノート
読み込み中…